Dr. Joshua Hare, M.D. director of the interdisciplinary stem cell institute at the Miller School of Medicine, and his team have authored a new study demonstrating that mesenchymal stem cells can create bone cells by triggering a biochemical switch. The study was conducted using mice that lacked the enzyme that regulates the body’s level of nitric oxide, a molecule which helps transmit signals throughout the body. When MSCs were inserted into the mice, it was found that the mice produced more bone cells and fewer fat cells, which resulted in leaner mice with increased bone production. This exciting discovery has the potential to help treat varying conditions including but not limited to osteoporosis and obesity. One in three woman and one in five men over the age of 50 will experience a hip fracture due to osteoporosis. By providing a way to produce more bone cells, MSCs create a potential to help keep people active for much longer and thus improve overall quality of life. Click here to read the full article. The post Study Promotes Bone Growth as Possible Therapy for Osteoporosis and Obesity appeared first on Celltex Therapeutics.